Table 2.
Clinical and histopathological attributes of mCMT cases.
| Clinical and gross findings |
Histopathological findings |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Percentage∗ (n) | Characteristic | Percentage∗ (n) | ||||||
| Mammary gland involved | Tumor classification | ||||||||
| Thoracic | Cranial | 11 (4) | Carcinoma | Simple | 17 (6) | ||||
| Caudal | 14 (5) | Complex | 36 (13) | ||||||
| Abdominal | Cranial | 19 (7) | Sarcoma | 3 (1) | |||||
| Caudal | 39 (14) | Carcinosarcoma | 39 (14) | ||||||
| Inguinal | 80 (29) | Others | 5 (2) | ||||||
| Consistency/texture of tumor mass | Tumor grading∗∗ (n = 19) | ||||||||
| Soft | 39 (14) | Grade I | 31.5 (6) | ||||||
| Hard | 61 (22) | Grade II | 31.5 (6) | ||||||
| External hemorrhage | Grade III | 37 (7) | |||||||
| Present | 28 (10) | Angiogenesis | |||||||
| Absent | 72 (26) | Present | 97 (35) | ||||||
| Inflammatory signs | Absent | 3 (1) | |||||||
| Present | 36 (13) | Lymphatic emboli | |||||||
| Absent | 64 (23) | Present | 19 (7) | ||||||
| Ulceration | Absent | 81 (29) | |||||||
| Present | 17 (6) | Cyst formation | |||||||
| Absent | 83 (30) | Present | 22 (8) | ||||||
| Tumor size | Absent | 78 (28) | |||||||
| ≤3 cm | 14 (5) | Necrosis | |||||||
| 3–5 cm | 17 (6) | Present | 69 (25) | ||||||
| ≥5 cm | 69 (25) | Absent | 31 (11) | ||||||
∗
Rounded up to the nearest tenth.
∗∗
Only for carcinoma cases as per the guidelines of Misdorp 2002.